- In Treatment
- After Treatment and Survivorship
- CBTF Publications
- Loss, Grief and Bereavement
CANCER RATES IN U.S. KEEP FALLING: HOW CAN PEDIATRIC BRAIN TUMOR PATIENTS ALSO MOVE THIS DIRECTION
“(Reuters) - Cancer death rates are continuing to fall, dropping by 1.8 percent per year in men and 1.6 percent per year in women between 2004 and 2008, according to the American Cancer Society's annual report on cancer statistics released on Wednesday.
Advances in cancer screening and treatment have prevented more than a million total deaths from cancer since the early 1990s, according to the report.
But the influential cancer group said new cases of seven less-common cancers rose in the past decade, suggesting more could be done in America's 40-year war on cancer.
Death rates fell in all four of the most common cancers, lung, colon, breast and prostate, with lung cancer accounting for nearly 40 percent of the total drop in men and breast cancer account for 34 percent of the total decline in women.
According to Central Brain Tumor Registry of the United States, the incidence rate of pediatric brain tumor cases has grown from 4.3 cases per 100,000 in 2005-2006 to 4.8. This is a rise from 3410 new cases to 4150 new cases.
Pediatric brain tumor patients have seen a rise in five year survival rates from 64.8 percent to 72.5 percent. However this means survivors living with the multitude of cognitive, physical, medical and emotional changes which continue long after treatment ends. These changes impact the family, peer relationships, educational achievement, dating and fertility, and employment,
One way we can continue to assist in improving the long term outcomes of brain tumor patients is through the support of the Children’s Brain Tumor Tissue Consortium (CBTTC). The CBTTC is a unique research platform in which tumor tissue is processed for comprehensive molecular (e.g., DNA, RNA, and protein) analysis using state-of-the-art methods and the data results of that analysis, together with new brain tumor models and relevant clinical information, are sent back to the participating institutions. In comparison to tissue banks, the CBTTC actively stimulates research by providing high-quality data that can be rapidly and efficiently analyzed by participating institutions. For more information on CBTTC and how to support it see http://www.cbtf.org/learn/tissue-consortium-faq.
For a link to the full article on cancer rates click http://www.reuters.com/article/2012/01/05/us-usa-cancer-rates-idUSTRE8032A420120105